HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Charles J Schneider Selected Research

Charles J Schneider Research Topics

Disease

8Neoplasms (Cancer)
01/2022 - 06/2007
3Breast Neoplasms (Breast Cancer)
08/2014 - 12/2009
2Head and Neck Neoplasms (Head and Neck Cancer)
12/2019 - 07/2011
2Disease Progression
12/2019 - 02/2009
2Squamous Cell Carcinoma of Head and Neck
12/2019 - 11/2018
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2018 - 01/2002
2Neoplasm Metastasis (Metastasis)
01/2018 - 06/2007
1Adenocarcinoma
01/2022
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2022
1Margins of Excision
01/2022
1Circulating Neoplastic Cells
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
05/2021
1Hemorrhage
12/2019
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
01/2019
1Hyperalgesia
01/2019
1Anemia
11/2018
1Injection Site Reaction
11/2018
1Exanthema (Rash)
11/2018
1Fever (Fevers)
11/2018
1Chills
11/2018
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2017
1Tonsillar Neoplasms
06/2015
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2015
1Leukemia
11/2012
1Mucositis
07/2011
1Stomatitis
07/2011
1Xerostomia
07/2011
1Prostatic Neoplasms (Prostate Cancer)
06/2007
1Thrombocytopenia (Thrombopenia)
01/2002

Drug/Important Bio-Agent (IBA)

3PlatinumIBA
10/2020 - 01/2019
3Cetuximab (Erbitux)FDA Link
11/2018 - 02/2009
2Bevacizumab (Avastin)FDA Link
12/2019 - 07/2018
2Monoclonal AntibodiesIBA
12/2019 - 02/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2014 - 11/2012
2Paclitaxel (Taxol)FDA LinkGeneric
08/2014 - 11/2012
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2014 - 11/2012
1Circulating Tumor DNAIBA
01/2022
1Carcinoembryonic AntigenIBA
01/2022
1Cell-Free Nucleic AcidsIBA
01/2022
1Messenger RNA (mRNA)IBA
10/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2019
1IceIBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2019
1VTX-2337IBA
11/2018
1Biomarkers (Surrogate Marker)IBA
11/2018
1Pemetrexed (MTA)FDA Link
07/2018
1Carboplatin (JM8)FDA LinkGeneric
07/2018
1Irinotecan (Camptosar)FDA LinkGeneric
10/2017
1sacituzumab govitecanIBA
10/2017
1Type I DNA Topoisomerases (Topoisomerase I)IBA
10/2017
1Immunoconjugates (Immunoconjugate)IBA
10/2017
1Fibroblast Growth Factor 7FDA Link
07/2011
1AnthracyclinesIBA
12/2009
1taxaneIBA
12/2009
1enzastaurinIBA
12/2009
1Erlotinib Hydrochloride (CP 358,774)FDA Link
02/2009
1Growth Factor ReceptorsIBA
02/2009
1ErbB Receptors (EGF Receptor)IBA
02/2009
1Glycoproteins (Glycoprotein)IBA
06/2007
1CytokinesIBA
06/2007
1Transforming Growth Factor beta (TGF-beta)IBA
06/2007
1EndoglinIBA
06/2007
1Topotecan (Hycamtin)FDA LinkGeneric
01/2002
1GemcitabineFDA Link
01/2002
1Cisplatin (Platino)FDA LinkGeneric
01/2002

Therapy/Procedure

8Therapeutics
01/2022 - 01/2002
5Drug Therapy (Chemotherapy)
12/2019 - 02/2009
2Immunotherapy
05/2021 - 11/2018
2Radiotherapy
01/2018 - 06/2015
2Adjuvant Chemotherapy
08/2014 - 11/2012
1Cryotherapy (Therapy, Cold)
01/2019
1Combination Drug Therapy (Combination Chemotherapy)
11/2018
1Chemoradiotherapy
07/2011